Nephron heterogeneity: Clue to the pathogenesis of essential hypertension and effectiveness of angiotensin-converting enzyme inhibitor treatment

This publication has 17 references indexed in Scilit:

• On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship
  Journal Of Hypertension, 1988
• Two forms of vasoconstriction in systemic hypertension
  The American Journal of Cardiology, 1987
• Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients
  Progress in Cardiovascular Diseases, 1978
• Disparate Patterns of Aldosterone Response During Diuretic Treatment of Hypertension
  Annals of Internal Medicine, 1977
• Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme
  New England Journal of Medicine, 1977
• Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin
  The American Journal of Medicine, 1976
• Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profiles
  The American Journal of Medicine, 1973
• Essential Hypertension: Renin and Aldosterone, Heart Attack and Stroke
  New England Journal of Medicine, 1972
• Control of renin release.
  Physiological Reviews, 1967
• Prolonged Infusions of Angiotensin II and Norepinephrine and Blood Pressure, Electrolyte Balance, and Aldosterone and Cortisol Secretion in Normal Man and in Cirrhosis with Ascites*
  Journal of Clinical Investigation, 1965